InCube Labs is a life sciences R&D lab focused on developing and commercializing breakthrough medical innovations. InCube is led by Mir Imran, a prolific healthcare innovator, entrepreneur and investor. InCube's multi-disciplinary team is dedicated to identifying unmet clinical needs and creating solutions that have the potential to dramatically improve patient care. InCube's researchers and scientists work across multiple therapeutic areas in pursuit of breakthrough healthcare innovations, the most promising of which become InCube companies. The InCube team is currently working on new therapies for the treatment of atrial fibrillation, epilepsy, iron deficiency anemia, brain cancer and obesity as well as remote patient monitoring technologies, among other projects. Mir Imran, InCube's Chairman & CEO, has founded more than 20 life sciences companies and holds more than 250 patents. The company is located in Silicon Valley and San Antonio. The InCube network includes InCube Labs; InCube portfolio companies such as Rani Therapeutics, Intrapace, Neurolink, Corhythm, Theracle and iBridge; InCube Ventures, a healthcare venture fund; VentureHealth, a healthcare crowdfunding portal; and Modulus, a medical device manufacturing company co-located with InCube.